In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing
- PMID: 21352585
- PMCID: PMC3056728
- DOI: 10.1186/1479-0556-9-4
In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing
Abstract
Background: Both adenoviral and lentiviral vectors have been successfully used to induce bone repair by over-expression of human bone morphogenetic protein 2 (BMP-2) in primary rat bone marrow stromal cells in pre-clinical models of ex vivo regional gene therapy. Despite being a very efficient means of gene delivery, there are potential safety concerns that may limit the adaptation of these viral vectors for clinical use in humans. Recombinant adeno-associated viral (rAAV) vector is a promising viral vector without known pathogenicity in humans and has the potential to be an effective gene delivery vehicle to enhance bone repair. In this study, we investigated gene transfer in rat and human bone marrow stromal cells in order to evaluate the effectiveness of the self-complementary AAV vector (scAAV) system, which has higher efficiency than the single-stranded AAV vector (ssAAV) due to its unique viral genome that bypasses the rate-limiting conversion step necessary in ssAAV.
Methods: Self-complementaryAAV2 encoding GFP and BMP-2 (scAAV2-GFP and scAAV2-BMP-2) were used to transduce human and rat bone marrow stromal cells in vitro, and subsequently the levels of GFP and BMP-2 expression were assessed 48 hours after treatment. In parallel experiments, adenoviral and lentiviral vector mediated over-expression of GFP and BMP-2 were used for comparison.
Results: Our results demonstrate that the scAAV2 is not capable of inducing significant transgene expression in human and rat bone marrow stromal cells, which may be associated with its unique tropism.
Conclusions: In developing ex vivo gene therapy regimens, the ability of a vector to induce the appropriate level of transgene expression needs to be evaluated for each cell type and vector used.
Figures



Similar articles
-
Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.Adv Exp Med Biol. 2006;585:31-48. doi: 10.1007/978-0-387-34133-0_3. Adv Exp Med Biol. 2006. PMID: 17120775
-
The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.J Spinal Disord Tech. 2008 Jul;21(5):372-9. doi: 10.1097/BSD.0b013e31814cf51d. J Spinal Disord Tech. 2008. PMID: 18600149
-
Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.Bone. 2008 May;42(5):921-31. doi: 10.1016/j.bone.2007.12.216. Epub 2008 Jan 5. Bone. 2008. PMID: 18295562
-
Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo.Acta Pharmacol Sin. 2010 Jul;31(7):821-30. doi: 10.1038/aps.2010.67. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581855 Free PMC article.
-
Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.Acta Orthop Suppl. 2007 Apr;78(325):1-64. Acta Orthop Suppl. 2007. PMID: 17427340 Review.
Cited by
-
Gene delivery to bone.Adv Drug Deliv Rev. 2012 Sep;64(12):1331-40. doi: 10.1016/j.addr.2012.03.013. Epub 2012 Mar 26. Adv Drug Deliv Rev. 2012. PMID: 22480730 Free PMC article. Review.
-
Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications.Gene Ther. 2021 Dec;28(12):729-739. doi: 10.1038/s41434-020-0182-4. Epub 2020 Aug 17. Gene Ther. 2021. PMID: 32807899
-
Progresses towards safe and efficient gene therapy vectors.Oncotarget. 2015 Oct 13;6(31):30675-703. doi: 10.18632/oncotarget.5169. Oncotarget. 2015. PMID: 26362400 Free PMC article. Review.
-
Injectable BMP-2 gene-activated scaffold for the repair of cranial bone defect in mice.Stem Cells Transl Med. 2020 Dec;9(12):1631-1642. doi: 10.1002/sctm.19-0315. Epub 2020 Aug 12. Stem Cells Transl Med. 2020. PMID: 32785966 Free PMC article.
References
-
- Colterjohn NR, Bednar DA. Procurement of bone graft from the iliac crest. An operative approach with decreased morbidity. J Bone Joint Surg Am. 1997;79:756–759. - PubMed
-
- Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG. et al.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123–2134. - PubMed
-
- Marsell R, Einhorn TA. Emerging bone healing therapies. J Orthop Trauma. pp. S4–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources